istock-629430458pablo_k-1-

Pablo_K / iStockphoto.com

11 September 2018Americas

Federal Circuit sides with Broad Institute in CRISPR clash

The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

13 March 2019 Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.

USPTO revives fight over CRISPR patents

27 June 2019 The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.

Sigma-Aldrich submits CRISPR petition at USPTO

23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

More on this story

Sigma-Aldrich submits CRISPR petition at USPTO

23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

USPTO revives fight over CRISPR patents

27 June 2019 The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.

LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

13 March 2019 Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.

More on this story

Sigma-Aldrich submits CRISPR petition at USPTO

23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

USPTO revives fight over CRISPR patents

27 June 2019 The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.

LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

13 March 2019 Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.

More features

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Pfizer infringed haemophilia therapy patent, says court

Cooley adds ex-Gowling partner